Contraindications
Ranitic® should not be taken if there is a known allergy to the active ingredient Ranitidine. Even if hypersensitivity reactions to drugs with similar active substances as Ranitidine are known, a physician should be consulted regarding the use of Ranitic. Since the active substance contained in Ranitic® can trigger an acute porphyria attack, the drug Ranitic® in the active substance quantities 150mg and 300mg should not be taken if the disease of acute porphyria is known to be present.
Even with lower dosages, a doctor should be informed and consulted about the use of the drug. If you have certain complaints that can be associated with a stomach tumor, you should have the complaints clarified by the attending physician before taking Ranitic®, otherwise the typical upper abdominal complaints can be masked by taking the drug. The treating physician should also be informed about these problems in the case of kidney dysfunction, as the active ingredient contained in Ranitic® is excreted via the kidneys and for this reason dysfunctions of the kidney can cause significantly higher concentrations of the active ingredient in the body.
If the presence of a duodenal ulcer is suspected, this must be clarified before taking Ranitic®. If there is an infection with the germ Helicobacter Pylori, the bacterium should be removed in any case. It should also be noted that Ranitic® can influence the effect of other medications when taken simultaneously with other medications.
For example, Ranitic® can acutely increase the effect of the blood sugar lowering drug Glipizid. The effect of the sleeping pills Midozalam and Triazolam can also be enhanced by taking Ranitic® at the same time. Drugs whose intake depends on the amount of stomach acid present can also be influenced by taking Ranitic® at the same time.
Previous experience has shown that pregnancy problems do not usually occur if Ranitic® is taken at the same time as the triazolam. Nevertheless, a doctor should be consulted before taking Ranitic®. As the active ingredient Ranitidine passes into the breast milk when Ranitic® is taken, it is recommended not to take the drug during the breastfeeding period.The short-term use of Ranitic® for heartburn in children under 16 years of age is not recommended. In general, the use of Ranitic® is not recommended for children under the age of two.
